Disrupting the α-synuclein-ESCRT interaction with a peptide inhibitor mitigates neurodegeneration in preclinical models of Parkinson's disease.
Nat Commun
; 14(1): 2150, 2023 04 19.
Article
in En
| MEDLINE
| ID: mdl-37076542
Full text:
1
Database:
MEDLINE
Main subject:
Parkinson Disease
Limits:
Animals
/
Female
/
Humans
/
Male
Language:
En
Year:
2023
Type:
Article